文献速递甲状腺疾病

全外显子组测序在甲状腺发育不全所致先天性甲状腺功能减退症中的应用

Whole-Exome Sequencing in Congenital Hypothyroidism Due to Thyroid Dysgenesis.
PubMed 文献 · Thyroid · 2022-04-25

本研究通过病例对照设计,对36例非近亲结婚的散发性非综合征型甲状腺发育不全所致先天性甲状腺功能减退症(NS-CHTD)患者及301名未患病对照进行全外显子组测序,未发现罕见蛋白改变变异的富集。42%的病例携带先天性甲状腺功能减退症相关基因的致病或可能致病变异,8%的病例携带多个基因变异,但WES未能确定NS-CHTD的遗传病因,提示其病因复杂,需在更大队列中进一步研究。

要点

  • NS-CHTD患者一级亲属相对风险增加40倍,单卵双胎不一致率为92%。
  • 经多重检验校正后,NS-CHTD中未观察到罕见蛋白改变变异的富集。
  • 42%的病例检出12个CH基因的21个致病或可能致病变异,8%为寡基因变异。

核心结论

  • 对特征明确的NS-CHTD队列进行WES无偏分析未发现新的易感基因,WES未能在NS-CHTD病例中确定遗传病因,证实该病病因复杂。
  • 42%的病例检出罕见致病或可能致病变异,8%的病例携带多个甲状腺发育不全或激素合成障碍相关基因变异,但这些变异不能解释发育不全中观察到的甲状腺功能减退变异性。
  • 需要在更大队列和/或新的发现方法中进一步研究。

研究设计与样本

  • 病例对照研究,比较36例非近亲结婚的NS-CHTD病例(33例舌部甲状腺异位,3例无甲状腺,基于诊断时锝高锝酸盐闪烁显像)与301名未患病对照的全外显子组,评估罕见蛋白改变变异的富集。
  • 采用基于基因的负荷检验并以错误发现率校正的无偏方法。
  • 基于计算机预测工具,在27个既往与先天性甲状腺功能减退症(CH)(甲状腺发育不全[TD]和激素合成障碍)相关的基因中鉴定所有罕见致病和可能致病变异。

主要发现

  • NS-CHTD一级亲属相对风险增加40倍(1/100,一般人群出生患病率为1/4000),单卵双胎不一致率为92%。
  • 经多重检验校正后,NS-CHTD中未观察到罕见蛋白改变变异的富集。
  • 42%的病例检出致病或可能致病变异(12个CH基因中的21个变异)。
  • 8%的病例携带一个以上基因的变异(寡基因组),其受累严重程度不高于单基因病例;激素合成障碍相关基因携带蛋白改变变异的病例受累严重程度也不高于无此类变异的病例。

局限性

  • 需要在更大队列和/或新的发现方法中进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Context: Congenital hypothyroidism due to thyroid dysgenesis (CHTD) is a predominantly sporadic and nonsyndromic (NS) condition of unknown etiology. NS-CHTD shows a 40-fold increase in relative risk among first-degree relatives (1 in 100 compared with a birth prevalence of 1 in 4000 in the general population), but a discordance rate between monozygotic (MZ) twins of 92%. This suggests a two-hit mechanism, combining a genetic predisposition (incomplete penetrance of inherited variants) with postzygotic events (accounting for MZ twin discordance). Objective: To evaluate whether whole-exome sequencing (WES) allows to identify new predisposing genes in NS-CHTD. Methods: We performed a case-control study by comparing the whole exome of 36 nonconsanguineous cases of NS-CHTD (33 with lingual thyroid ectopy and 3 with athyreosis, based on technetium pertechnetate scintigraphy at diagnosis) with that of 301 unaffected controls to assess for enrichment in rare protein-altering variants. We performed an unbiased approach using a gene-based burden with a false discovery rate correction. Moreover, we identified all rare pathogenic and likely pathogenic variants, based on in silico prediction tools, in 27 genes previously associated with congenital hypothyroidism (CH) (thyroid dysgenesis [TD] and dyshormonogenesis). Results: After correction for multiple testing, no enrichment in rare protein-altering variants was observed in NS-CHTD. Pathogenic or likely pathogenic variants (21 variants in 12 CH genes) were identified in 42% of cases. Eight percent of cases had variants in more than one gene (oligogenic group); these were not more severely affected than monogenic cases. Moreover, cases with protein-altering variants in dyshormonogenesis-related genes were not more severely affected than those without. Conclusions: No new predisposing genes were identified following an unbiased analysis of WES data in a well-characterized NS-CHTD cohort. Nonetheless, the discovery rate of rare pathogenic or likely pathogenic variants was 42%. Eight percent of the cases harbored multiple variants in genes associated with TD or dyshormonogenesis, but these variants did not explain the variability of hypothyroidism observed in dysgenesis. WES did not identify a genetic cause in NS-CHTD cases, confirming the complex etiology of this disease. Additional studies in larger cohorts and/or novel discovery approaches are required.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Larrivée-Vanier S, Jean-Louis M, Magne F, et al. Whole-Exome Sequencing in Congenital Hypothyroidism Due to Thyroid Dysgenesis. Thyroid. 2022. PMID: 35272499. doi:10.1089/thy.2021.0597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。